NASDAQ:ERYP

ERYTECH Pharma (ERYP) Stock Forecast, Price & News

$0.94

0.00 (0.00%)

(As of 06/1/2023 ET)

Compare

Today's Range: $0.86
▼
$0.94
50-Day Range: $0.70
▼
$1.22
52-Week Range: $0.30
▼
$1.47

Volume: 3,985 shs
Average Volume: 107,945 shs
Market Capitalization: $32.07 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Profile Chart Competitors Financials Institutional Ownership Headlines SEC Filings Short Interest Social Media

About ERYTECH Pharma (NASDAQ:ERYP) Stock

ERYTech Pharma SA is a biopharmaceutical company, which develops medical products. The firm conducts research and development of innovative red blood cell-based therapeutics for cancer and orphan diseases. The company was founded by Pierre-Olivier Goineau and Yann Godfrin on November 22, 2004 and is headquartered in Lyon, France.

Receive ERYP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ERYTECH Pharma and its competitors with MarketBeat's FREE daily newsletter.

ERYP Stock News Headlines

May 30, 2023 | americanbankingnews.com

Head-To-Head Contrast: ERYTECH Pharma (NASDAQ:ERYP) vs. Amgen (NASDAQ:AMGN)

May 26, 2023 | americanbankingnews.com

ERYTECH Pharma S.A. (NASDAQ:ERYP) Sees Large Increase in Short Interest

June 1, 2023 | Edge On The Street (Ad)

The $193 Billion US-China War You Don't Know About

They're fighting for control of lithium – a key ingredient in EVs and clean energy technology. It's arguably the most important commodity of the 21st century. China owns 80% of global supply. But the US plans to grab a massive slice of the lithium market, which is forecasted to quadruple to $193 billion by 2028, according to Fortune Business Insights.

May 26, 2023 | americanbankingnews.com

ERYTECH Pharma (NASDAQ:ERYP) & Surface Oncology (NASDAQ:SURF) Head-To-Head Review

May 24, 2023 | finance.yahoo.com

ERYTECH Announces the Availability of the Documents for its Annual General Meeting to be held on June 23, 2023

May 24, 2023 | msn.com

Pharma Stocks Lead European Equities Sharply Lower in Wednesday Trading

May 23, 2023 | businesswire.com

PHERECYDES Announces the Availability of the Exemption Document Relating to the Proposed Combination With Erytech Pharma

May 23, 2023 | finance.yahoo.com

ERYTECH announces the availability of the exemption document relating to the proposed combination with Pherecydes

June 1, 2023 | Edge On The Street (Ad)

The $193 Billion US-China War You Don't Know About

May 23, 2023 | msn.com

Pharma Stocks Lead European Equities Modestly Lower in Tuesday Trading

May 19, 2023 | msn.com

European Equities Rise in Friday Trading, Poised to End Week Higher

May 17, 2023 | msn.com

Pharma Stocks Weigh Down European Equities in Wednesday Trading

May 16, 2023 | finance.yahoo.com

Monthly information related to total number of voting rights and shares composing the share capital _May 15, 2023

May 16, 2023 | msn.com

Pharma Stocks, Vodafone Lead European Equities Lower in Tuesday Trading

May 15, 2023 | finanznachrichten.de

Erytech Pharma S.A.: ERYTECH Provides Update on the Announced Combination with PHERECYDES

May 15, 2023 | finance.yahoo.com

ERYTECH Provides Update on the Announced Combination with PHERECYDES

May 12, 2023 | finance.yahoo.com

Monthly information related to total number of voting rights and shares composing the share capital _April 30, 2023

May 12, 2023 | msn.com

European Equities Traded as American Depositary Receipts Lower Again in Wednesday US Trading

May 9, 2023 | finanznachrichten.de

Erytech Pharma S.A.: ERYTECH Provides Business and Financial Update for the First Quarter of 2023

May 9, 2023 | theglobeandmail.com

Micro Cap Bid Up Right Before Opening Bell

May 9, 2023 | finance.yahoo.com

ERYTECH Provides Business and Financial Update for the First Quarter of 2023

May 9, 2023 | finance.yahoo.com

ERYTECH Provides Business and Financial Update for the First Quarter of 2023

April 17, 2023 | finanznachrichten.de

Erytech Pharma S.A.: ERYTECH Announces Approval to Transfer its Listing to the Nasdaq Capital Market

April 17, 2023 | seekingalpha.com

ERYTECH receives approval to transfer its listing to Nasdaq Capital Market

April 17, 2023 | finance.yahoo.com

ERYTECH Announces Approval to Transfer its Listing to the Nasdaq Capital Market

April 14, 2023 | msn.com

Pharma Stocks Lead European Equities Lower Friday Trading, But Index Poised to End Week Higher

April 12, 2023 | msn.com

Pharma Stocks Lead European Equities Higher Wednesday Trading

See More Headlines

ERYP Price History

30 days | 90 days | 365 days | Advanced Chart

ERYP Company Calendar

Today: 6/01/2023
Fiscal Year End: 12/31/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biological products, except diagnostic
Sub-Industry: N/A
Sector: Medical
Current Symbol: NASDAQ:ERYP
CUSIP: N/A
CIK: 1624422
Web: www.erytech.com
Phone: (347) 874-4438
Fax: 33-4-78-75-56-29
Employees: 196
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: 0.32
Current Ratio: 3.65
Quick Ratio: 3.65

Sales & Book Value

Annual Sales: $32.66 million
Price / Sales: 0.91
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $0.80 per share
Price / Book: 1.09

Miscellaneous

Outstanding Shares: 34,120,000
Free Float: 33,458,000
Market Cap: $29.69 million
Optionable: Not Optionable
Beta: 2.68

Key Executives

Gil Beyen
Chief Executive Officer & Director

Eric Soyer
Chief Operating & Financial Officer

Iman El-Hariry
Chief Medical Officer

Jérôme Bailly
Chief Quality Officer & Deputy General Manager

Françoise Horand-Phothirath
Director-Research & Development Operations

Key Competitors

View All Competitors

ERYP Stock - Frequently Asked Questions

How have ERYP shares performed in 2023?: ERYTECH Pharma's stock was trading at $0.3301 at the beginning of the year. Since then, ERYP shares have increased by 163.6% and is now trading at $0.8703.
View the best growth stocks for 2023 here.
Are investors shorting ERYTECH Pharma?: ERYTECH Pharma saw a increase in short interest during the month of May. As of May 15th, there was short interest totaling 95,000 shares, an increase of 138.7% from the April 30th total of 39,800 shares. Based on an average trading volume of 138,400 shares, the days-to-cover ratio is presently 0.7 days.
View ERYTECH Pharma's Short Interest.
What other stocks do shareholders of ERYTECH Pharma own?: Based on aggregate information from My MarketBeat watchlists, some companies that other ERYTECH Pharma investors own include Allena Pharmaceuticals (ALNA), Exelixis (EXEL), Madrigal Pharmaceuticals (MDGL), Sesen Bio (SESN), Cidara Therapeutics (CDTX), Fate Therapeutics (FATE), Gilead Sciences (GILD), MEI Pharma (MEIP), Verastem (VSTM) and ACADIA Pharmaceuticals (ACAD).
When did ERYTECH Pharma IPO?: (ERYP) raised $125 million in an initial public offering (IPO) on Friday, November 10th 2017. The company issued 5,300,000 shares at a price of $23.00-$24.00 per share. Jefferies, Cowen and Oddo BHF served as the underwriters for the IPO and JMP Securities was co-manager.

What is ERYTECH Pharma's stock symbol?: ERYTECH Pharma trades on the NASDAQ under the ticker symbol "ERYP."
How do I buy shares of ERYTECH Pharma?: Shares of ERYP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is ERYTECH Pharma's stock price today?: One share of ERYP stock can currently be purchased for approximately $0.87.
How much money does ERYTECH Pharma make?: ERYTECH Pharma (NASDAQ:ERYP) has a market capitalization of $29.69 million and generates $32.66 million in revenue each year.
How many employees does ERYTECH Pharma have?: The company employs 196 workers across the globe.
How can I contact ERYTECH Pharma?: ERYTECH Pharma's mailing address is 60 AVENUE ROCKEFELLER BATIMENT ADENINE, LYON I0, 69008. The official website for the company is www.erytech.com. The company can be reached via phone at (347) 874-4438, via email at investors@erytech.com, or via fax at 33-4-78-75-56-29.

This page (NASDAQ:ERYP) was last updated on 6/1/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial